Open Access Peer-Reviewed
Editorial

Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration

Ranibizumab e bevacizumab intravítreo no tratamento da neovascularização de coróide extrafoveal da degeneração macular relacionada à idade

Aaron Brock Roller1; Miguel Hage Amaro2

DOI: 10.1590/S0004-27492009000500016

1,University of Iowa Department of Ophthalmology Hospitals and Clinics
2,Federal University of São Paulo Department of Ophthalmology


Dimension

© 2024 - All rights reserved - Conselho Brasileiro de Oftalmologia